Concepedia

Anamitro Banerjee

AB

Statistics

Publications

17

Citations

1.3K

H-Index

15

Active since

1997

Affiliations

Center for Drug Evaluation and Research(Current)

University of North Dakota

University of Maryland, College Park

United States Food and Drug Administration

Center for Devices and Radiological Health

Anamitro Banerjee is an author at Center for Drug Evaluation and Research specializing in chemistry, natural sciences, and photochemistry.

Publications per year

1997–2022

17

Publications

17

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

Aviva C. Krauss, Xin Gao, Liang Li et al. · Clinical Cancer Research · 2018 · 327 citations · Full text

, , +17

FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer

Preeti Narayan, Tatiana M. Prowell, Jennifer Gao et al. · Clinical Cancer Research · 2020 · 166 citations · Full text

, , +17

FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation–Associated Advanced Ovarian Cancer

Sanjeeve Balasubramaniam, Julia A. Beaver, Sara Horton et al. · Clinical Cancer Research · 2017 · 164 citations

, , +17

FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy

Gwynn Ison, Lynn Howie, Laleh Amiri‐Kordestani et al. · Clinical Cancer Research · 2018 · 131 citations

, , +12

Protecting Groups That Can Be Removed through Photochemical Electron Transfer:  Mechanistic and Product Studies on Photosensitized Release of Carboxylates from Phenacyl Esters

Anamitro Banerjee, Daniel E. Falvey · The Journal of Organic Chemistry · 1997 · 90 citations

, , +16

1–5 of 17